NephroDI Therapeutics
Rare Disease Therapeutics · Biotechnology
Facts
as of Nov 17, 2026About Us NephroDI Therapeutics is developing a novel AMPK activator as a first-in-class potential therapy for Nephrogenic Diabetes Insipidus (NDI). The genesis of this technology began with Drs.
- Employees
- 1-10estimated range
- Website
- nephrodi.com
Sources: company registers, GLEIF, Wikidata, the company's site, Alion job postingsReport a mistake
What the registers and the postings say about this employer.
Sanctions lists
OFAC SDN, EU consolidated
No match
Phishing reports
OpenPhish, Phishing.Database
None
Layoff notices
US WARN notices on file
None
Full employer checkScam signs in adverts, mail records, visa registers, domain history
Sources: company registers, the Alion truth index, OFAC and EU sanctions lists, US WARN notices
Newsroom
top 10%Web presenceof 133.2M domains by links, Common Crawl
Sources: the outlets named on each headline, each story once
